• Join over 1.2 million students every month
  • Accelerate your learning by 29%
  • Unlimited access from just £6.99 per month

Tumour markers and their role in Cancer diagnostics

Extracts from this document...

Introduction

Page | ________________ ________________ Tumour markers and their role in Cancer diagnostics Amra Iuoop BIO 01/181010 HND Biomedical sciences BMS 30 June 2012 Cancer, or a neoplasm, is best defined by the British oncologist Willis (Robbins, 2010), ?A neoplasm is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated with that of the normal tissues and persists in the same manner after cessation of the stimuli which evoked the change?. Tumour markers, also called serum markers or biomarkers, are metabolized molecular products that are secreted by neoplastic tissue and biochemically processed in cells or body fluids (Cortez, 2011). They are secreted by normal cells as well as by cancer cells; nevertheless the quantity is usually quite high in cancerous conditions. Consequently, the presence of a malignant tumour can be identified more or less by the detection of a specific tumour marker. Tumour markers are reckoned to be useful in the following (Sharma, 2009): Screening: Identification of seemingly healthy people who perhaps have a high risk of developing cancer. Diagnosis: Identification of a disease on the knowledge extent of clinical findings and laboratory tests. Staging and treatment planning. Planning of the treatment course after identification of the cancer?s stage. Monitoring: Determination of the cancer?s response to treatment. Prognosis: Predication of possible outcome or progress of the cancer. Recurrence. Reappearance of the cancer after successful treatment. The National Cancer Institute (2011) states that tumour markers are represented by various chemical groups: including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids. ...read more.

Middle

Treatment with the use of Herceptin, an antibody, on breast cancer is ineffective unless the presence of the HER-2 gene in the tumour (Szabo, 2008). Epigenetic changes such as abnormal DNA methylation are good prognostic markers; however it can be applied clinically only after further clarifying certain issues such as determining sensitivity and specificity of the marker, and the ability of its performance comparatively better than other markers (Widschwendter, 2006). Carcinoembryonic antigen (CEA), an oncofetal antigen, acts as a prognostic marker to check the aggressiveness of colorectal cancer. The CEA levels are elevated proportionally to the progressing tumour and vice versa (American Society of Clinical Oncology, 1996). Monitoring and Recurrence Of all the uses, Sharma (2009) states that tumour markers are perhaps mostly used clinically in monitoring the cancer. They are significant in the identification of the treatment response from the cancer patient, where alterations of the tumour marker level can be observed when the status of the cancer changes in response to therapy. When an unresponsiveness to a particular therapy is monitored, it is terminated, shifted to another treatment and as a result, probable toxicities of the treatment on patient can be evaded (Schrohl, 2003). Treatment efficacy of germ cell tumours can be monitored using the combination of two tumour markers: Human chorionic gonadotropin (HCG), a placental product, and AFP (Vastag, 1999). In addition to that, serum quantification of monoclonal immunoglobulins is utilized for monitoring response to therapy in patients with multiple myeloma (Koulieris, 2012). Moreover time management is essential when using tumour markers for the purpose of monitoring. ...read more.

Conclusion

and Thompson, I.M. (2007) 'Biomarkers for prostate cancer detection'. The Journal of urology, 178(6), pp.2252-9. Robbins and Cotran. (2010) Pathological Basis of Disease. 8th edition. Pennsylvania: Saunders. Schrohl, A.-S., Holten-Andersen, M., Sweep, F., Schmitt, M., Harbeck, N., Foekens, J. and Brunner, N. (2003) 'Tumor markers: from laboratory to clinical utility'. Molecular & cellular proteomicsâ¯: MCP, 2(6), pp.378-87. Sharma S. (2009) ‘Tumor markers in clinical practice: General principles and guidelines’. Indian Journal of Medical and Paediatric Oncology, 30(1), 1-8. Szabo, L. (2008) ‘Breakout drug Herceptin brings new age in breast cancer care’. USA Today, 15 October [ONLINE] Available at: http://www.usatoday.com/news/health/2008-10-12-herceptin_N.htm (Accessed: 30 June 2012). Thompson, I., Pauler, D., Goodman, P., Tangen, C., Lucia, M., Parnes, H., Minasian, L., Ford, L., Lippman, S., Crawford, E., Crowley, J. and Coltman, C. (2004) ‘Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter’. New England Journal of Medicine, 350, 2239-46. Thompson, M.P., and Kurzrock, R. (2004) ‘Epstein-Barr virus and cancer’. Clinical Cancer Research, 10, 803-21. Thor, A.D., Moore, D.H., Edgerton, S.M., Kawasaki, E.S., Reihsaus, E., Lynch, H.T., Marcus, J.N., Schwartz, L., Chen, L-C., Mayall, B.H. and Smith, H.S. (1992) ‘Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers’. Journal of the National Cancer Institute, 84(11), 845-855. Tuxen MK, Soletormos G, and Dombernowsky P. (1995) ‘Tumor markers in the management of patients with ovarian cancer’. Cancer Treatment Reviews, 21, 215-45. Vastag B. (1999) ‘Testicular cancer seen as “stalking horse” for other cancers’. Journal of the National Cancer Institute, 91, 1801–3. Widschwendter, M. and Menon, U., (2006) 'Circulating methylated DNA: a new generation of tumor markers'. Clinical cancer researchâ¯: an official journal of the American Association for Cancer Research, 12(24), pp.7205-8. ...read more.

The above preview is unformatted text

This student written piece of work is one of many that can be found in our University Degree Applied Biology section.

Found what you're looking for?

  • Start learning 29% faster today
  • 150,000+ documents available
  • Just £6.99 a month

Not the one? Search for your essay title...
  • Join over 1.2 million students every month
  • Accelerate your learning by 29%
  • Unlimited access from just £6.99 per month

See related essaysSee related essays

Related University Degree Applied Biology essays

  1. Marked by a teacher

    Should a DNA profile be taken at birth?

    3 star(s)

    Creating a DNA profile of all newborns is a tool for the future, but at today's development has both advantages and disadvantages. Such advantages are; identification of individuals, disaster victim identification, immigration applications, determining adopted siblings, paternity testing and most importantly criminal justice.

  2. Bi technology and food security: The clue for a new green revolution?

    golden rice, enriched with vitamin A, fed into the system via the CGIAR and NARS ( Reviving global poverty reduction: what role for GM plant? www.worldbank.org ) GM research is therefore being steered to crops irrelevant for poor farmers, in some cases can be even harmful to the poor.

  1. This experiment was carried out to separate and characterize the protein mixture which contained ...

    1/10 dilution sample = 917.14 �g/ml Concentration of haemoglobin in 0.1ml undiluted sample = 917.14x10 = 9171.4�g/ml Mass of haemoglobin in 0.1ml undiluted sample = 9171.4 �g Since 0.2ml of original sample was added to the column, mass of haemoglobin in undiluted sample = = 18342.8�g Mass of haemoglobin in

  2. Isolation &amp;amp; Characterisation of Proteins. The purpose of conducting this experiment is to ...

    x 10-3 g 1ml consists of = 1.714 x 10-5 g/ml Mass of haemoglobin eluent fraction (3%) in tube 1, �g Concentration of haemoglobin = 1.714 x 10-5 g/ml Thus, mass of haemoglobin, �g = 1.714 x 10-5 g/ml x 106 = 17.143�g Same method of calculation was applied to

  1. What Limits if any should be placed on the use of the following Biotechnologies. ...

    The implications of sharing Blackford?s opinions and carrying it forward to stem cell research may be severe, especially regarding the debate on whether it would be permissible to carry out ?therapeutic cloning?.

  2. Food Science -Experiments to Determine the Properties and Uses of Enzymes in Food Preperation.

    The usage of peroxidase is important in agricultural applications because it provides useful information regarding on the types of conditions that are suitable for storing fruits and vegetables and most importantly, for extending the shelf life of it (Doe, 2010).

  1. Optimization of DNA Extraction from Medically and Environmentally important Fungi for Polymerase Chain Reaction

    Fungi cannot photosynthesize (they are heterotrophic, like animals) Fungi absorb their food (they are osmotrophic) They mostly develop very diffuse bodies made up of a spreading network of very narrow, tubular, branching filaments called hyphae. These filaments exude enzymes, and absorb food, at their growing tips.

  2. Regional anatomy - case studies of the spinal region

    is a unique peripheral nerve. It is truly an only motor nerve that does not carry any sensory fibers whatsoever, thus, patient had no sensory numbness when the trapezium muscle contracts. Most other motor nerves of the upper limb, such as the ulnar nerve, and most nerves to skeletal muscle,

  • Over 160,000 pieces
    of student written work
  • Annotated by
    experienced teachers
  • Ideas and feedback to
    improve your own work